Print

Print


Sunday, 1 April, 2001, 23:25 GMT 00:25 UK
BBC NEWS OnLine

Parkinson's sufferers 'failed by GPs'

Parkinson's causes shaking and muscle stiffness
Parkinson's patients are not getting the right treatment from their GPs
says a campaigning charity. The Parkinson's Disease Society (PDS)
claims more than half of the UK's GPs are not giving the correct
treatment for newly-diagnosed sufferers.

It says a survey of 400 GPs across the UK showed that over 50% were
prescribing drug treatments contrary to best practice guidelines.

These guidelines recommend that GPs should refer all new patients with
suspected Parkinson's for specialist confirmation of diagnosis and a
drug therapy regime.

But Mary Baker, chief executive of the PDS, said many GPs were failing
to refer and this was having a detrimental effect on the patients they
were actually trying to help.

"Unfortunately in their eagerness to help patients, many GPs may not
realise that by initiating treatment instead of referring all patients with
suspected Parkinson's disease they could actually be doing more harm
than good in the longer term."

Age bias
The survey also revealed an age bias - 94% of GPs said they would
always refer patients aged under 50.

Just over half said they would refer patients aged 71 or over, but only
11% said they would refer patients aged over 81.

Ms Baker said she was very worried by this: "Such age
discrimination is disconcerting, particularly considering our ageing
population, and has no place in the management of a condition which
predominantly affects elderly people."

The concerns of the PDS are backed by Dr Douglas MacMahon, a
member of the primary care task force, which set up the original
guidelines.

He said: "The research shows that 95% of GPs who initiate treatment for
new patients prescribe the drug levodopa.

"While initially very effective in controlling symptoms, after
only five years of treatment with levodopa, disabling side-effects will
occur in at least 50% of patients."

"Due to long term complications associated with levodopa, its use
should be delayed for as long as possible and other treatments, such as
dopamine agonists, should be initiated in early onset Parkinson's
disease."

Dr Stephen Henry, another member of the task force, agreed specialist
referral was the best way of patients getting the most appropriate
treatment.

"A typical GP is likely to have about four patients on his list with the
disease, so it is very difficult to keep abreast of the advances. "

"Specialists on the other hand, or at least doctors with a specialist
interest in Parkinson's disease are in a much better position to offer
patients a wealth of knowledge of not only the disease but also the
latest drug therapies."

The Royal College of General Practitioners (RCGP) said it would like to
see more GPs getting better access to specialists in this field.

Professor Chris Drinkwater, fellow of the RCGP, said: "It would be good
to see named Parkinson's disease specialists, perhaps with the support
of a specialist nurse, working with Primary Health Care Trusts, to
ensure GPs within a region have a rapid and easy access to specialist
advice and support and to education and training about Parkinson's
Disease."

http://news.bbc.co.uk/hi/english/health/newsid_1251000/1251730.stm

*******

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn